Sign in
Taking peopleNo phase

WhatsApp reminders for blood sugar testing after pregnancy with gestational diabetes

Tests WhatsApp reminders for follow-up glucose testing in women after gestational diabetes.

Key facts

Who runs it
University of Sao Paulo General Hospital
Where
Brazil1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Screening for Dysglycemia During Postpartum Period in Women With GDM
Status
Recruiting
People taking part
182 people, planned
Started
24 Mar 2026
Expected to end
Nov 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Whatsapp message
Record updated
4 May 2026

Who can take part

The trial is looking for women who had gestational diabetes (diabetes during pregnancy) and gave birth at HC-FMUSP. It tests WhatsApp reminders for a sugar test after birth.

Sex
Women only.
Disease stage
Gestational diabetes diagnosed by IADPSG criteria. A 75g oral glucose tolerance test must be scheduled 6 to 12 weeks after delivery.
Biomarker or test result
Fasting blood sugar ≥ 92mg/dL (5.1 mmol/L) at first test, OR a 75g glucose tolerance test with fasting ≥ 92mg/dL (5.1 mmol/L), 1h ≥ 180mg/dL or 2h ≥ 153mg/dL.
Main reasons for not taking part
  • Withdrawing consent.
  • Not finishing the glucose test because of vomiting (left out of the second analysis only).
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • Diagnosis of gestational diabetes mellitus, according to diagnostic criteria proposed by the IADPSG, namely:
  • initial fasting blood glucose ≥ 92mg/dL OR
  • 75g oral glucose tolerance test with fasting ≥ 92mg/dL or after 1h ≥ 180mg/dL or after 2h ≥ 153mg/dL Delivery performed at HC-FMUSP Scheduling of the 75g oral glucose tolerance test between 6 and 12 weeks after delivery Agreement with the informed consent form

Who cannot take part

  • Withdrawal of consent Failure to complete the TOTG exam due to vomiting (exclusion from analysis 2 only)

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Sex
  • Gestational diabetes mellitus

This trial is currently available in Brazil.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Gestational diabetes mellitus (GDM) is one of the most common clinical conditions in pregnancy, with an increasing incidence due to the rise in overweight women and the postponement of motherhood. It is associated with perinatal complications and an increased risk of developing prediabetes and type 2 diabetes after delivery. Therefore, it is recommended that a 75g oral glucose tolerance test (OGTT-75g) be performed between 6 and 12 weeks postpartum. Despite its relevance, the rate of adherence to the test is low. Recent studies also indicate that measuring blood glucose one hour after the overload may be more sensitive than the traditional two-hour measurement in the early detection of dysglycemia. This study aims to evaluate strategies for qualifying the screening of metabolic changes in the postpartum period among women with GDM. The objectives are: (1) to analyze the impact of sending reminders via WhatsApp on the attendance rate for the 75g OGTT; and (2) to compare the frequency of prediabetes and diabetes diagnoses using two different diagnostic strategies applied to the same test-the traditional (fasting and 2-hour blood glucose) and the alternative (fasting and 1-hour blood glucose).

The 2 groups in the trial

  • ControlNo study treatment, for comparison

    Control Group (current practice): will not receive reminder messages for the exam.

  • Intervention groupTreatment being tested

    Intervention Group: will receive automatic reminder messages via WhatsApp on days D-7 and D-3 in relation to the scheduled date for the exam. If the patient does not attend, she will receive a single additional message on the following business day, offering the possibility of rescheduling. Rescheduled exams will not receive new reminders. The message sent will contain a read receipt request to ensure that the patient has received the text. If the patient requests to reschedule the exam before the originally scheduled date, we will consider the new date as D for sending reminder messages.

    Treatment: Whatsapp message

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Strategies for Improving the Detection of Dysglycemia in the Postpartum Period in Women With Gestational Diabetes: Electronic Reminders and New Diagnostic Criteria
Plain-language title
WhatsApp reminders for blood sugar testing after pregnancy with gestational diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07489456, who can take part
Record updated
4 May 2026